CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL

This adverse event was reported 13 times

These drugs are most commonly taken by patients reporting CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL:

# Drug Count
0 METOPROLOL SUCCINATE 3
1 IMATINIB 2
2 METOPROLOL SUCCINATE ER TABLETS 2
3 ALBUTEROL 1
4 ALBUTEROL SULFATE 1
5 ALENDRONATE SODIUM 1
6 ASPIRIN 1
7 ASPIRIN 325 MG 1
8 ASPIRIN 81 MG 1
9 CABOZANTINIB 1
See all common drugs associated with CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL

CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FERRIC CARBOXYMALTOSE 1 0.0002
1 RIVASTIGMINE 1 0.0001
2 PROCHLORPERAZINE 1 0.0000
3 METOPROLOL SUCCINATE 3 0.0000
4 ERGOCALCIFEROL 1 0.0000
5 METOPROLOL SUCCINATE ER TABLETS 2 0.0000
6 TORSEMIDE 1 0.0000
7 DEXLANSOPRAZOLE 1 0.0000
8 CABOZANTINIB 1 0.0000
9 ECULIZUMAB 1 0.0000
See all drugs enriched for association with CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL

CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinesterase Inhibitor [EPC] 1 0.0001
1 Provitamin D2 Compound [EPC] 1 0.0000
2 Phenothiazine [EPC] 1 0.0000
3 Complement Inhibitor [EPC] 1 0.0000
4 Cardiac Glycoside [EPC] 1 0.0000
5 Interleukin-23 Antagonist [EPC] 1 0.0000
6 Calcium [EPC] 1 0.0000
7 Aldosterone Antagonist [EPC] 1 0.0000
8 Opioid Agonist [EPC] 1 0.0000
9 Loop Diuretic [EPC] 1 0.0000
See all drug classes enriched for association with CARDIAC ELECTROPHYSIOLOGIC STUDY ABNORMAL